
Anne L. Holleran
Examiner (ID: 14328, Phone: (571)272-0833 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1643 |
| Total Applications | 775 |
| Issued Applications | 297 |
| Pending Applications | 125 |
| Abandoned Applications | 356 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5278530
[patent_doc_number] => 20090130662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Method for Diagnosis of Prostate Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/886263
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10538
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886263
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886263 | Method for Diagnosis of Prostate Cancer | Mar 13, 2006 | Abandoned |
Array
(
[id] => 5693712
[patent_doc_number] => 20060153859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Ganglioside-KLH conjugate vaccine with QS-21'
[patent_app_type] => utility
[patent_app_number] => 11/375549
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 32681
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375549 | Ganglioside-KLH conjugate vaccine with QS-21 | Mar 12, 2006 | Abandoned |
| 10/031722 | Human monoclonal antibodies to her2/neu | Mar 5, 2006 | Abandoned |
Array
(
[id] => 5403506
[patent_doc_number] => 20090238820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'ANTI-MAdCAM ANTIBODY COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/815259
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 28259
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815259 | ANTI-MAdCAM ANTIBODY COMPOSITIONS | Mar 1, 2006 | Abandoned |
Array
(
[id] => 5666602
[patent_doc_number] => 20060171952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'JAM-3 and antibodies that bind thereto'
[patent_app_type] => utility
[patent_app_number] => 11/347057
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24273
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347057 | JAM-3 and antibodies that bind thereto | Feb 1, 2006 | Abandoned |
Array
(
[id] => 5349310
[patent_doc_number] => 20090004671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Marker Protein For Use In Diagnosis Of Pancreatic Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/908694
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5832
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004671.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908694
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908694 | Marker Protein For Use In Diagnosis Of Pancreatic Cancer | Jan 25, 2006 | Abandoned |
Array
(
[id] => 8176240
[patent_doc_number] => 08178102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Emulsified composition for dilution and cancer vaccine composition'
[patent_app_type] => utility
[patent_app_number] => 11/814270
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 12042
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814270
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814270 | Emulsified composition for dilution and cancer vaccine composition | Jan 18, 2006 | Issued |
Array
(
[id] => 4792160
[patent_doc_number] => 20080293134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing Same'
[patent_app_type] => utility
[patent_app_number] => 11/794430
[patent_app_country] => US
[patent_app_date] => 2005-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 41694
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293134.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794430
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794430 | Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing Same | Dec 27, 2005 | Abandoned |
Array
(
[id] => 4960036
[patent_doc_number] => 20080274461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Perinucleolar Compartment Markers for Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/794346
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9802
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794346 | Perinucleolar Compartment Markers for Cancer | Dec 21, 2005 | Abandoned |
Array
(
[id] => 5776308
[patent_doc_number] => 20060104948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Interferon immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 11/314227
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5842
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104948.pdf
[firstpage_image] =>[orig_patent_app_number] => 11314227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/314227 | Interferon immunotherapy | Dec 20, 2005 | Abandoned |
Array
(
[id] => 4812830
[patent_doc_number] => 20080193461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Use of Angiopoietins in Tumor Therapy'
[patent_app_type] => utility
[patent_app_number] => 11/793452
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17734
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793452 | Use of Angiopoietins in Tumor Therapy | Dec 19, 2005 | Abandoned |
Array
(
[id] => 4676129
[patent_doc_number] => 20080213759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Novel Angiogenesis Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/722799
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16187
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213759.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722799
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722799 | Novel Angiogenesis Inhibitor | Dec 19, 2005 | Abandoned |
Array
(
[id] => 4758890
[patent_doc_number] => 20080311116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Process for the Determination of Inflammatory Process and Pharmaceutical Compositions for the Treatment Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/792677
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13712
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311116.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792677
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792677 | Process for the determination of inflammatory processes and pharmaceutical compositions for the treatment thereof | Dec 12, 2005 | Issued |
Array
(
[id] => 5872968
[patent_doc_number] => 20060165703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/290896
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 35022
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290896 | Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis | Nov 28, 2005 | Abandoned |
Array
(
[id] => 4971266
[patent_doc_number] => 20070111268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Methods, compositions and kits for use in prognosis, characterization and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/273184
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20425
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111268.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273184
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273184 | Methods, compositions and kits for use in prognosis, characterization and treatment of cancer | Nov 13, 2005 | Abandoned |
Array
(
[id] => 6594662
[patent_doc_number] => 20100062426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'AGR2 and TFF3 Regulation in the Diagnosis and Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/092626
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1774
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062426.pdf
[firstpage_image] =>[orig_patent_app_number] => 12092626
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/092626 | AGR2 and TFF3 Regulation in the Diagnosis and Treatment of Cancer | Nov 2, 2005 | Abandoned |
Array
(
[id] => 4663545
[patent_doc_number] => 20080254452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Pkp3 Oncogene as a Prognostic Indicator for Lung Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/577485
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4236
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254452.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577485
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577485 | PKP3 oncogene as a prognostic indicator for lung cancer | Oct 17, 2005 | Issued |
Array
(
[id] => 348958
[patent_doc_number] => 07495074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => 'Isolated proteins MAGE-4 and MAGE-41'
[patent_app_type] => utility
[patent_app_number] => 11/253240
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 16456
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/495/07495074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253240 | Isolated proteins MAGE-4 and MAGE-41 | Oct 16, 2005 | Issued |
Array
(
[id] => 4866310
[patent_doc_number] => 20080145369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Autocrine Growth Factor Receptors and Methods'
[patent_app_type] => utility
[patent_app_number] => 11/665359
[patent_app_country] => US
[patent_app_date] => 2005-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 4882
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665359
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665359 | Autocrine Growth Factor Receptors and Methods | Oct 11, 2005 | Abandoned |
Array
(
[id] => 177923
[patent_doc_number] => 07655631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Pharmaceutical preparations and methods for inhibiting tumors'
[patent_app_type] => utility
[patent_app_number] => 11/240937
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 34
[patent_no_of_words] => 25522
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655631.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240937
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240937 | Pharmaceutical preparations and methods for inhibiting tumors | Sep 29, 2005 | Issued |